The ability to reprogram somatic cells to generate induced pluripotent stem (iPS) cells has generated tremendous interest and discussion since iPS cells were first produced from mouse cells in 2006 ...
The CiRA Foundation has published a paper in Med that provides an update on the iPS Cell Stock Project. The reprogramming of peripheral or cord blood from 7 donors who are homozygous for HLA-A, -B, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results